Science Current Events | Science News | Brightsurf.com
 

Prostate Cancer Screening Current Events | Prostate Cancer Screening News

Page 1 of 119 | 2953 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America.   view more (2007-06-19)

Popular Magazines Don't Inform Men About Prostate and Colon Cancer Screening
Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men's magazines. When articles are available, they often do not provide the information necessary for the reader to make... view more (2004-09-08)

PSA velocity's clinical usefulness remains unclear
Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool.   view more (2007-10-10)

Annual prostate cancer screening test appears to save lives
Men who have a yearly blood test to examine their prostate specific antigen levels are nearly three times less likely to die from prostate cancer than those who don't have annual screenings.   view more (2005-10-20)

Men with prostate cancer want screening despite doubts over effectiveness of treatment
Most men with prostate cancer strongly advocate routine testing for prostate specific antigen (PSA), despite evidence that aggressive screening and treatment does not reduce deaths, according to two studies in this week's BMJ. In the first study, researchers at the University of Oxford interviewed... view more (2002-10-02)

Early warning: PSA testing can predict advanced prostate cancer
Researchers who showed that a single prostate specific antigen (PSA) test at age 50 or under could predict the presence of prostate cancer up to 25 years later, (regardless of clinical significance) have now found that a single PSA can be used to predict advanced prostate cancer.   view more (2008-02-15)

More prostate cancer screening has little effect on detection of aggressive cancer
More prostate cancers were detected among men who were screened every two years than men screened every four years, according to a study published online August 28 in the Journal of the National Cancer Institute.   view more (2007-08-29)

Should the UK lower the age for prostate cancer detection?
Prostate cancer screening occurs in many countries ahead of evidence from ongoing trials. In many countries, early detection (including the UK, when practised), and opportunistic screening commences at 50 years, but a lower age limit has recently been adopted in the USA based on two studies that... view more (2007-11-16)

Preventive health exams may provide opportunities for cancer screening
Health plan members who receive preventive health examinations, as opposed to going to a physician only when they are sick, appear more likely to undergo testing for colorectal, breast and prostate cancers.   view more (2007-03-27)

Health risk behaviors associated with lower prostate specific antigen awareness
According to a study conducted at Columbia University Mailman School of Public Health, health risk behaviors such as smoking and obesity are associated with lower awareness of the Prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer screening.   view more (2008-08-28)

Should older men be screened for prostate cancer?
Screening for prostate cancer in older men has been problematic. While this form of cancer can be fatal, it often progresses so slowly that men are more likely to die from some other disease. Aggressive treatments such as radical prostatectomy or radiation therapy may eradicate the cancer but have... view more (2006-05-02)

Some screening tests should not be advocated
Certain screening tests for cancer are of unproved value and should not be advocated, argues a senior doctor in this week's BMJ.   view more (2004-02-05)

PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate... view more (2003-03-05)

Genes may play role in risk assessment for prostate cancer among Hispanics and caucasians
Genetic differences may explain the greater risk for prostate cancer among Caucasian men compared with Hispanic men, which could help clinicians predict who is more likely to develop the disease.   view more (2008-05-15)

Antioxidant supplementation not associated with decreased risk of prostate cancer
Intakes of dietary or supplemental antioxidants were not associated with a decreased risk of prostate cancer among men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.   view more (2006-02-15)

African-Americans with prostate cancer more likely to have family history of prostate, breast cancer
African-American men with prostate cancer were more likely to report a family history of prostate cancer and breast cancer among siblings than men who did not have prostate cancer, according to researchers at the University of Michigan Comprehensive Cancer Center.   view more (2006-12-04)

Online tool supports more dialogue on prostate cancer risk
A comprehensive, clinical nomogram tool, the Sunnybrook Prostate Cancer Risk Calculator - the first to use all known risk factors for prostate cancer - is available online to help men determine individual prostate cancer risk in consultation with their primary care physician.   view more (2008-02-05)

Reactions to 'false-positive' prostate cancer screenings assessed
Men who get a "false-positive" prostate cancer result — an abnormal screening test followed by a biopsy indicating no evidence of cancer — appear more likely to worry about their subsequent risk of cancer and report more problems with sexual function compared to men with... view more (2007-03-05)

Prostate cancer screening: a suitable case for ethical treatment, says Dutch specialist
Men should be informed about the controversy over prostate cancer screening before having a test, ECCO 11 - the European Cancer Conference was told today (Thursday 25 October) in Lisbon.   view more (2001-10-22)

International research team identifies gene that promotes prostate cancer
Together with an international research team, researchers from VTT Technical Research Centre of Finland have developed an effective method for the screening and identification of genes that under normal conditions suppress cancer growth. The method enabled the discovery of a new cancer gene, which,... view more (2004-11-24)

Men need to know more about cancer
Clare Moynihan and colleagues at the Institute of Cancer Research in Sutton, Surrey reported their research today, Thursday 2 September, at The British Psychological Society's Division of Health Psychology Annual Conference, in Leeds. They interviewed men about their knowledge of prostate and... view more (1999-08-20)

Anti-inflammatory drugs may mask prostate cancer marker
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications.   view more (2008-09-08)

Low-risk prostate cancer patients face overtreatment
Many low-risk prostate cancer patients are being overtreated and might fare better if doctors monitored the cancer until treatment was necessary.   view more (2006-08-16)

University of Kent Study Aims To Improve Information And Support Needs For Older Men With Prostate Cancer
The Centre for Health Services Studies (CHSS) at the University of Kent is currently engaged in an exploratory study of the information and support needs for men aged 75+ with prostate cancer.   view more (2004-11-03)

MR imaging helps predict recurrence in prostate cancer patients
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return.   view more (2007-05-07)
Page 1 of 119 | 2953 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com